Navigation Links
Santaris Pharma A/S Expands Executive Team, Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA-targeted Drug Development Programs
Date:10/28/2009

HOERSHOLM, Denmark and SAN DIEGO, California, October 28 /PRNewswire/ --

- Industry Expert Mark Wedel, MD, FACP Joins as Vice President and Chief Medical Officer Responsible for Global Clinical Development Programs and Therapeutic Portfolio Management

- Stuart Mackey, JD joins as Vice President Strategy and Chief Business Officer to Drive Global Business Development for Proprietary RNA-targeted Locked Nucleic Acid (LNA) Drug Platform

- New Executives Will be Based out of Recently Established US Subsidiary Aimed at Fostering new Partnerships and Increasing Visibility With Capital Markets

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA drugs targeted to disease-related mRNAs and microRNAs, has expanded its executive team with the appointment of Mark Wedel, MD, FACP as Vice President and Chief Medical Officer and Stuart Mackey, JD as Vice President Strategy and Chief Business Officer. Internally and through its partners, Santaris Pharma A/S has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090921/360545 )

The newly appointed executives will hold global responsibility for advancing Santaris Pharma A/S proprietary RNA-targeted Locked Nucleic Acid (LNA) Drug Platform programs and Drug Discovery Engine capabilities. Dr. Wedel will be responsible for global clinical development programs and therapeutic portfolio management. Mr. Mackey will lead Santaris Pharma A/S corporate strategy development, corporate communications and global business development programs.

"I am pleased to have Dr. Wedel and Mr. Mackey join our management team," said Søren Tulstrup, President and Chief Execut
'/>"/>

SOURCE Santaris Pharma A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015   Rock Creek Pharmaceuticals, Inc., ... focused on the treatment of chronic inflammatory disorders, announced ... to the Company,s Board of Directors with the recent ... a new director. Michael Mullan ... Pharmaceuticals, said, "Dr. Samuel,s experience in advancing biotechnology products ...
(Date:4/21/2015)... , April 21, 2015  Direct contracting continues ... as aptitude marks its second anniversary.  With over ... platform, single hospital entities, large integrated delivery systems ... that cover medical surgical items, clinical preference products ... cost effective - complementary contracting strategy, aptitude seeks ...
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 2Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 3Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 4Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 5Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 6Rock Creek Pharmaceuticals Appoints New Director and Provides Notice of Settlement of Derivative Litigation 7Healthcare's first direct contracting market celebrates second anniversary 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3
(Date:4/21/2015)... (PRWEB) April 21, 2015 The joint ... today it is opening its first freestanding emergency room ... Chandler, Arizona and will be licensed under Dignity Health ... Dignity Health and Adeptus Health joint venture. , Tim ... and Mercy Gilbert Medical Centers said the new facility ...
(Date:4/21/2015)... NJ & New York, NY (PRWEB) April 21, ... leading global provider of advanced delivery technologies and ... products, today announced the launch of ADVASEPT™ Lock, ... safe and efficient delivery of injectable medications. Easily ... combining a safe, convenient and functional container closure ...
(Date:4/21/2015)... Carinsurancehints.com has released a new blog ... impact on auto insurance prices . , ... prices. Clients should review their insurance options before deciding ... under several forms. Some of the popular policies provide ... compare online rates and find the best prices in ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 This ... & Related Skin Types, Inc.® (FIRST) will publish a ... The campaign will run throughout the month of May ... It Matters to Someone." The positioning was chosen ... this rare skin disorder and to help support our ...
(Date:4/21/2015)... Carinsuranceshoppingsource.com has released a new blog ... insurance plans . , Comprehensive auto insurance is ... situations. The coverage limit can also be high and ... protect a car against fire damage, vandalism, theft and ... no longer difficult and it can help drivers find ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2
... Kiadis Pharma,announced today that its lead product ATIR ... Food and Drug Administration (FDA) as a therapy ... Disease (GvHD),following allogeneic bone marrow transplantation. ATIR is ... enter clinical phase III,studies in 2008. "This ...
... to treat high blood pressure and enlargement of ... caused by post-traumatic stress disorder, Alzheimer,s disease, depression ... antipsychotic medication, appears to block the increase of ... Science University and Portland Veterans Affairs Medical Center ...
... Scientists at Cold Spring Harbor Laboratory (CSHL) have developed a ... genome that is more powerful and more economical than methods ... to be a boon to many kinds of research, including ... genes implicated in major diseases such as cancer and schizophrenia. ...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) today reported financial ... the quarter ended September 30, 2007, the Company reported a ... to a net loss of,$62.7 million, or $1.23 per share, ... per share, for the prior quarter ended June 30, 2007. ...
... and 6 ... other cities, RALEIGH, N.C., ... on the impact of new CPR techniques, the,results of which support the ... the study authors in a,presentation at the AHA,s Scientific Sessions on November ...
... Concise reporting would ensure validity of patient safety findings, group ... to be used as hospital safety rating tools have been ... the guidelines could help do away with misleading safety comparisons ... reporting patient safety data on their Web sites. While this ...
Cached Medicine News:Health News:FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 2Health News:FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation 3Health News:Blood pressure drug curbs brain damage from PTSD 2Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 2Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 3Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 4Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 5Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 6Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 7Health News:CV Therapeutics Reports 2007 Third Quarter Financial Results 8Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 2Health News:Raleigh in National Study, Shows Survival to Hospital Discharge After Cardiac Arrest Doubles With Improved CPR and Impedance Threshold Device 3
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
... to order tips. Each box contains 10,000 ... available in easy-to-open, re-sealable Bulk Packs of ... sealed with a tamper-proof strip which can ... Gilsons Diamond Tips. Bulk Packs are closed ...
... tips. Each box contains 1000 tips (5 bags ... tips (4 bags of 50 tips). Also available ... per pack. Bulk Packs are sealed with a ... quick access to Gilsons Diamond Tips. Bulk Packs ...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels - Ideal for use with CastAway System...
Medicine Products: